SEARCH BY
Try For Free 7-Day Free Trial
Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.
DEAL STATS | # |
---|---|
Overall | 8 of 10 |
Sector (Life Science) | 3 of 3 |
Type (Buyout (LBO, MBO, MBI)) | 6 of 8 |
Country (Denmark) | 2 of 4 |
Year (2021) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2020-12-15 |
Mallax Pharmaceuticals
Stockholm, Sweden Mallax Pharmaceuticals is a pharma company ‘ready-to-use’ with required pharmaceutical processes and licenses. Mallax Pharmaceuticals was founded in 2020 and is based in Stockholm, Sweden. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-15 |
NutraQ
Oslo, Norway NutraQ is a provider of subscription-based health and wellness products in the Nordic region. NutraQ was founded in 2002 and is based in Oslo, Norway. |
Sell | - |